Cardiovascular Diseases

Antihypertensives Stimulate Type 2 and 4 Angiotensin II Receptors Linked to Lower Dementia Risk

A US cohort study suggested that initiation of medications for high blood pressure that stimulate vs inhibit type 2 and 4 angiotensin II receptors may result in a lower risk of incident dementia. The study included 57 773 patients aged 65 years or older with incident high blood pressure from January 1, 2006, through December 31, 2018; women 62.9%; mean age, 73.8 years; 5.1% Black, 2.7% Hispanic; 86.9% White, and 5.4% Other individuals (American Indian, Asian, other, or unknown race and ethnicity). During a median of 6.9 years of follow-up, the unadjusted incidence density rate of Alzheimer disease and related dementias (ADRD) was 2.2 cases per 100 person-years for the group receiving regimens that stimulate type 2 and 4 angiotensin II receptors (angiotensin II receptor type 1 blockers, dihydropyridine calcium channel blockers, thiazide diuretics) compared with 3.1 cases per 100 person-years for the group receiving regimens that inhibit type 2 and 4 angiotensin II receptors (angiotensin-converting enzyme inhibitors, β-blockers, nondihydropyridine calcium channel blockers) and 2.7 cases per 100 person-years for the group receiving mixed treatment regimens. In adjusted Cox proportional hazards regression modeling, stimulating treatment was associated with a statistically significant 16% reduction in the hazard of ADRD compared with inhibiting treatment (hazard ratio, 0.84). Mixed regimen use was also associated with reduced hazards of ADRD compared with the inhibiting group (hazard ratio, 0.90). The findings need to be confirmed in a randomized trial. Source: https://jamanetwork.com/

hyangiu

Recent Posts

Dose Response of Physical Activity in CVD and Mortality

Two recent studies highlight the importance of physical activity volume and intensity in reducing cardiovascular…

1 day ago

Faster Walking Pace May Reduce Risk of Cardiac Arrhythmias

A prospective UK cohort study found that both self-reported average or brisk walking pace and…

2 days ago

4:3 Intermittent Fasting Outperforms Daily Caloric Restriction for Weight Loss

A U.S. randomized clinical trial found that 4:3 intermittent fasting (IMF) led to slightly greater…

4 weeks ago

Comparative CVD Efficacy of Newer Glucose-Lowering Drugs in Elderly T2D Patients

A Danish nationwide cohort study provided real world evidence that both glucagon-like peptide 1 receptor…

1 month ago

Efficacy of Non-Surgical and Non-Interventional Treatments in Low Back Pain

A systematic review and meta-analysis of placebo-controlled randomized trials showed that there is moderate certainty…

1 month ago

Statin Use Linked to Lower Risks of HCC and Liver Disease Progression

A US cohort study indicated that statin use may reduce the risks of hepatocellular carcinoma…

1 month ago

This website uses cookies.